-
Wang, Q, Pierce-Hoffman, E, Cummings, BB, Karczewski, KJ, Alföldi, J, Francioli, LC, Gauthier, LD, Hill, AJ, O’Donnell-Luria, AH, Team, GADCGADP, et al.
Landscape of multi-nucleotide variants in 125,748 human exomes and 15,708 genomes.
2024
view publication
-
Cummings, BB, Karczewski, KJ, Kosmicki, JA, Seaby, EG, Watts, NA, Singer-Berk, M, Mudge, JM, Karjalainen, J, Satterstrom, FK, O’Donnell-Luria, A, et al.
Transcript expression-aware annotation improves rare variant discovery and interpretation.
2024
view publication
-
Whiffin, N, Karczewski, KJ, Zhang, X, Chothani, S, Smith, MJ, Evans, DG, Roberts, AM, Quaife, NM, Schafer, S, Rackham, O, et al.
Characterising the loss-of-function impact of 5’ untranslated region variants in 15,708 individuals.
2024
view publication
-
Minikel, EV, Karczewski, KJ, Martin, HC, Cummings, BB, Whiffin, N, Rhodes, D, Alföldi, J, Trembath, RC, van Heel, DA, Daly, MJ, et al.
Evaluating potential drug targets through human loss-of-function genetic variation.
2024
view publication
-
McGregor, TL, Hunt, KA, Nioi, P, Mason, D, Ticau, S, Pelosi, M, Loken, PR, Finer, S, Griffiths, CJ, MacArthur, DG, et al.
Deep phenotyping of a healthy human HAO1 knockout informs therapeutic development for primary hyperoxaluria type 1.
2024
view publication